Skip to main content
SpringerLink
Log in

Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

In the present study the action of various cytokines as regulators of human melanocyte growth and differentiation was examined in vitro. Primary melanocyte cultures were obtained in complete medium free of 12-O-tetradecanoylphorbol-13-acetate or serum. First passage melanocytes were treated with various concentrations of recombinant tumour necrosis factor alpha and beta (rTNF-alpha, rTNF-beta), as well as with various recombinant interleukins (rIL-1a, rIL-1b, rIL-2, rIL-3, rIL-4 and rIL-6) for 6 days in complete medium and for 6 and 12 days in a mitogen-reduced medium variant. The 4-methylumbelliferyl heptanoate fluorometric microassay and Ki-67 staining were used for assessing cell proliferation, and the immunophenotype was evaluated using various monoclonal antibodies. Melanocyte proliferation in complete medium was inhibited by rTNF-alpha (−24%), rTNF-beta (−17%), rIL-1a (−21%), rIL-1b (−18%) and rIL-6 (−29%); in contrast, rIL-2, rIL-3 and rIL-4 had no antiproliferative effect. Measurements of Ki-67-positive nuclei confirmed these results. In the reduced medium variant, none of the above cytokines inhibited melanocyte proliferation. Recombinant TNF-alpha and rTNF-beta markedly reduced the expression of the pigment cell-associated antigens HMB-45 and K.1.2, and they enhanced the expression of VLA-2, ICAM-1 and HLA class I antigens and strongly induced HLA-DR. Similar changes were induced by rIL-1a, rIL-b and rIL-6, and rIL-2 decreased the expression of HLA class I antigens and of ICAM-1. In conclusion, several cytokines inhibited the growth and modulated the phenotype of melanocytes in vitro. Since these cytokines are major mediators of inflammatory processes, they may cause the pigmentary alterations seen after cutaneous inflammatory processes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abdel-Naser MB, Krüger-Krasagakes S, Krasagakis K, Gollnick H, Orfanos CE (1994) Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res 7: 1–8

    Google Scholar 

  • Al Badri AM, Foulis AK, Todd PM, Gariouch JJ, Gudgeon JE, Stewart DG, Gracie DG, Goudie RB (1993) Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J Pathol 169: 203–206

    Google Scholar 

  • Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S (1990) Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 94: 101S-107S

    Google Scholar 

  • Bochner BS, Charlesworth EN, Lichtenstein LM, Derse CP, Gillis S, Dinarello CA, Schleimer RP (1990) Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 86: 830–839

    Google Scholar 

  • Brüggen J, Sorg C (1983) Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies. Cancer Immunol Immunother 15: 200–205

    Google Scholar 

  • Cordell JL, Falini B, Erber WN, Ghosh A, Zainalabideen A, MacDonald S, Pulford KAF, Stein H, Masony DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-complexes). J Histochem Cytochem 32: 219–229

    Google Scholar 

  • Detmar M, Orfanos CE (1990) Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro. Arch Dermatol Res 282: 238–245

    Google Scholar 

  • Detmar M, Tenorio S, Hettmannsperger U, Ruszczak R, Orfanos CE (1992) Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol 98: 147–153

    Google Scholar 

  • Furue M, Ohtsuki M, Ogata F, Ishibashi Y (1991) Responsiveness to interleukin 4 and interleukin 2 of peripheral blood mononuclear cells in atopic dermatitis. J Invest Dermatol 96: 468–472

    Google Scholar 

  • Gerdes J, Schwab K, Lemke H, Stein H (1983) Production of mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20

    Google Scholar 

  • Gilchrest BA, Vrabel MA, Flynn E, Szabo G (1984) Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol 83: 370–376

    Google Scholar 

  • Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA (1986) Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 123: 195–203

    Google Scholar 

  • Halaban R, Ghosh S, Baird A (1987) bFGF is the putative natural growth factor for human melanocytes. In Vitro 23: 47–52

    Google Scholar 

  • Herlyn M, Kath R, Williams N, Valyi-Nagy I, Rodeck U (1990) Growth-regulatory factors for normal, premalignant and malignant human cells in vitro. Adv Cancer Res 54: 213–234

    Google Scholar 

  • Kirnbauer R, Charvat B, Schauer K, Köck A, Urbanski A, Forster E, Neuner P, Assmann I, Luger TA, Schwarz T (1992) Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for regulatory role of IL-6, IL-7, TNF-beta and UVB light. J Invest Dermatol 98: 320–326

    Google Scholar 

  • Klein CE, Steinmayer T, Kaufmann D, Weber L, Bröcker EB (1991) Identification of a melanoma progression antigen as integrin VLA-2. J Invest Dermatol 96: 281–284

    Google Scholar 

  • Krasagakis K, Garbe C, Krüger S, Orfanos CE (1991) Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not -alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol 97: 364–372

    Google Scholar 

  • Krüger-Krasagakes S, Krasagakis K, Garbe C, Diamantstein T (1995) Production of cytokines by human melanoma cells and melanocytes. Recent Results Cancer Res (in press)

  • Lampson LA, Levy R (1980) The populations of Ia-like molecules on a human B cell line. J Immunol 125: 293–299

    Google Scholar 

  • Malissen B, Rebai N, Liabeuf A, Mawas C (1982) Human cytotoxic T cell structures associated with expression of cytolysis I. Analysis at the clonal level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur J Immunol 12: 739–747

    Google Scholar 

  • Nordlund JJ, Amornsiripanitch S, Rheins LA, Abdel-Malek ZA, Boissy RE, Bell M (1988) Role of melanocyte in epidermal inflammatory and immune responses. Pigment Cell Res [Suppl] 1: 101–112

    Google Scholar 

  • Plaisance S, Rubinstein E, Alileche A, Han DS, Sahraoui Y, Mingari MC, Bellomo R, Rimoldi D, Colombo MP, Jasmin C, Carrel S, Azzarone B (1993) Human melanoma cells express a functional interleukin-2 receptor. Int J Cancer 55: 164–170

    Google Scholar 

  • Rothlein R, Dustin MC, Marlin SD, Springer TA (1986) A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137: 1270–1275

    Google Scholar 

  • Sauder DN, Stanulis-Praeger BM, Gilchrest BA (1988) Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte activating factor: implications for skin aging. Arch Dermatol Res 280: 71–76

    Google Scholar 

  • Schaumburg-Lever G, Metzler G, Kaiserling E (1991) Ultrastructural localization of HMB-45 binding sites. J Cutan Pathol 18: 432–435

    Google Scholar 

  • Schmidt JA, Mizel SB, Cohen D, Green I (1982) Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 128: 2177–2182

    Google Scholar 

  • Smoller BR, Hsu A, Krueger J (1990) HMB-45 monoclonal antibody recognizes and inducible and reversible melanocyte cytoplasmic protein. J Cutan Pathol 18: 315–322

    Google Scholar 

  • Suter L, Brüggen J, Bröcker EB, Sorg C (1985) A tumor-associated antigen expressed in melanoma cells with lower malignant potential. Int J Cancer 35: 787–791

    Google Scholar 

  • Swope VB, Abdel-Malek Z, Kassem LM, Nordlund JJ (1991) Interleukins 1a and 6 and tumor necrosis factor-a are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 96: 180–185

    Google Scholar 

  • Thestrup-Pedersen K, Larsen CS, Kristensen M, Zachariae C (1990) Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis. Acta Derm Venereol 70: 395–399

    Google Scholar 

  • Tsujisaki M, Igarashi M, Sakaguchi K, Eisinger M, Herlyn M, Ferrone S (1987) Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. J Immunol 138: 1310–1316

    Google Scholar 

  • Yohn JJ, Critelli M, Lyons MB, Norris DA (1990) Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol 95: 233–237

    Google Scholar 

  • Zouboulis ChC, Garbe C, Krasagakis K, Krüger S, Orfanos CE (1991) A fluorometric rapid microassay to identify antiproliferative compounds for human melanoma cells in vitro. Melanoma Res 1: 91–95

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University Medical Center Steglitz, The Free University of Berlin, Hindenburgdamm 30, D-12200, Berlin, Germany

    K. Krasagakis, C. Garbe, J. Eberle & C. E. Orfanos

Authors
  1. K. Krasagakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Eberle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krasagakis, K., Garbe, C., Eberle, J. et al. Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro. Arch Dermatol Res 287, 259–265 (1995). https://doi.org/10.1007/BF01105076

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01105076

Key words

Search

Navigation